Dieperink Willem, van der Horst Iwan C C, Nannenberg-Koops Jaqueline W, Brouwer Henk W, Jaarsma T, Nieuwland Wybe, Zijlstra Felix, Nijsten Maarten W N
Int J Cardiol. 2007 Jul 10;119(2):268-70. doi: 10.1016/j.ijcard.2006.07.151. Epub 2006 Oct 24.
Continuous positive airway pressure (CPAP) is standard treatment for patients with acute cardiogenic pulmonary edema. We describe a patient who had 21 episodes of acute cardiogenic pulmonary edema due to very poor patient compliance. This 64-year old man had end-stage congestive heart failure based on systolic left ventricular dysfunction following two myocardial infarctions. In addition to routine medical treatment 15 episodes of pulmonary edema were successfully treated with Boussignac continuous positive airway pressure (BCPAP). The BCPAP system is a simple, disposable, FDA-approved device that delivers positive pressure without a ventilator. This extraordinary case underscores the utility of the BCPAP system to avoid repeated intubation and mechanical ventilation in patients with cardiogenic pulmonary edema.
持续气道正压通气（CPAP）是急性心源性肺水肿患者的标准治疗方法。我们描述了一名患者，由于患者依从性极差，该患者发生了21次急性心源性肺水肿。这名64岁男性因两次心肌梗死后出现收缩期左心室功能障碍，处于终末期充血性心力衰竭状态。除常规药物治疗外，15次肺水肿发作通过布西尼亚克持续气道正压通气（BCPAP）成功治疗。BCPAP系统是一种简单、一次性使用、经美国食品药品监督管理局（FDA）批准的设备，无需呼吸机即可提供正压通气。这个特殊病例强调了BCPAP系统在避免心源性肺水肿患者反复插管和机械通气方面的实用性。
